Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Biotech Remove
Related Tags


November 2018
WeTuMoSuSaFrTh
21201918171615

Public Company News

Business Press Releases

Biotech Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12740227
By Stemology®
Ever Innovating, Stemology® Announces the Release of SRC-7™, Its Patent-Pending Advanced Stem Cell Technology Complex
12738941
By Keystone Symposia
Keystone Symposia, in partnership with Vienna BioCenter Research Institutes GMI, IMBA, IMP and MFPL, is pleased to announce a series of scientific research conferences to be held at Vienna BioCenter in Vienna, Austria.
12735061
By R3eWaste, Sonora Quest Laboratories
Two Phoenix-based companies working together to help each other and the environment.
By Ronald Reed CEO
Mr. Greg Hughes has been named today, National Sales Director of RGR Medical Porducts replacing William Mastro who is retiring. Mr. Hughes is a 20+ year pharmaceutical industry veteran.
12707107
By Rubix LS
Rubix LS is announcing today the launch of it's new Data & Research division to its core business function.  This is a step for Rubix LS to strongly position its expertise base to move as a technological think tank.
By RGR Medical Products
RGR Medical products as entered into an exclusive agreement to distribute NeuroZen Rehabilitation Technologies two new diabetic neurological pain management products.
By Scitech Engineering
Three leading British biotechnology businesses have obtained grant funding from Innovate UK to investigate the manufacture of a new class of medicines, targeting a range of clinical conditions through interaction with the human microbiome.
By Aspyron Inc
Aspyron Inc. announces a Tier II qualified offering under SEC Regulation A+ of up to 2,500,000 shares of common stock at a price of $.40 per share raising up to $1,000,000
By Keystone Symposia on Molecular & Cellular Biology
Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Tech Transfer for Medical Advances: Challenges and Opportunities Commercializing Academic Biomedical Research" on February 14, 2018 at 12:00 PM ET.
By BioPharma
Hughes BioPharma CEO/Founder Will Lead Panel on De-Risking BioPharma Alliances
12685137
By Rubix LS
Rubix LS creating footprints in more areas….now in Washington DC
By The Knowledge Group
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Kurt Briscoe, Member, Norris McLaughlin & Marcus, P.A.
12681405
By www.biosceptre.com
Biosceptre has received over £8M into its series A raise which will be used to resource the next stage of the companies' development; progression into the clinic of Biosceptre's first systemic products against novel oncology target nfP2X7.
By Protzek
The biotech company Protzek will be present at Milipol Paris between the 21st-24th of November. Held every two years, Milipol is world's leading event for homeland security professionals, receiving over 24,000 visitors from 143 countries.
By Partners4Access
Partners4Access (P4A), the specialists in orphan drug access, are launching a new webinar series, in line with their expanding activities in gene therapy.
By Partners4Access
Partners4Access will attend the Festival of Genomics in Boston on October 3rd, 2017. Sophie Schmitz, Managing Partner at P4A will be there meeting representatives of the research and patient community as well as the pharmaceutical industry.
By Vasuda Capital Management
As of today, we have confirmations of holding 366,355 shares of Inotek from shareholders who are in the favor of sale/liquidation which makes our investor group one of top 10 shareholders of Inotek.
By Vasuda Capital Management
Vasuda Capital Management (VCM), a Boston-area based investment management firm has sent a demand letter for inspection of books and records of Inotek Pharmaceuticals' Board of Directors (NASDAQ; ITEK) under Section 20 of the Delaware General Corporation.
By American Conference Institute
Hear from top leaders as they discuss best practices and tips for completing a thorough, cost-effective due diligence analysis in today's evolving life sciences climate.
By Eva Garland Consulting
Rapid Growth Motivates Relocation to North Hills Bank of America Tower

All Press Releases

12740227
By Stemology®
Ever Innovating, Stemology® Announces the Release of SRC-7™, Its Patent-Pending Advanced Stem Cell Technology Complex
12738941
By Keystone Symposia
Keystone Symposia, in partnership with Vienna BioCenter Research Institutes GMI, IMBA, IMP and MFPL, is pleased to announce a series of scientific research conferences to be held at Vienna BioCenter in Vienna, Austria.
12735061
By R3eWaste, Sonora Quest Laboratories
Two Phoenix-based companies working together to help each other and the environment.
By Partners4Access
Sophie Schmitz, Managing Partner of Partners4Access is to chair a panel discussion on rare diseases at the BioIndustry Association or BIA's event UK Bioscience Forum on October 18, 2018.
By Wareham Development
Newly Constructed Research Campus in Emeryville, Now Leasing
By Golden Helix, Inc.
Integrating CNV analysis into a NextGen sequencing clinical analytics platform
By Pharma Market Research Conference
Switzerland will host anticipated assembly of market research influencers
By PR&D
·      New combination reduces blocked nose without a pharmaceutical ingredient while simultaneously combating viral airway infections ·      Patent application submitted for innovative formulation Vienna, 7 August 2018.
By RGR Medical Products Inc
David Carter was hired as Vice President of retail accounts for RGR medical and in charge of promoting SleepEeze. Carter a 20 year veteran of retail sales, comes to RGR Medical from the successful sale of his own private business in 2016
By iHEAR® Medical
Public can now walk into their pharmacy and purchase the iHEARTEST™Kit to evaluate their hearing at home
By RGR Medical Products
RGR Medical Products Inc. has moved into its new facility located in Fishers, Indiana at 11807 Allisonville Road. RGR Medical has "outgrown" its previous office location at 11805 Pennsylvania Avenue in Carmel, Indiana.
By DevonMD
New partnership expands Devon MD's product footprint and global growth strategy
By Pharma Market Research Conference
Annual market research event starts next week in South San Francisco
By Ronald Reed CEO
Mr. Greg Hughes has been named today, National Sales Director of RGR Medical Porducts replacing William Mastro who is retiring. Mr. Hughes is a 20+ year pharmaceutical industry veteran.
By Pharma Market Research Conference
Register before May 25 to get the best price for returning West Coast event
By RGR Medical Products Inc.
RGR Medical Products has begun the the initial stage of a private placement memorandum to raise capital for its new sleeping aid product SleepEEZE. SleepEEZE is a patent pending over the counter supplement supporting sleep.
By LGM Pharma
LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Mr.
12707107
By Rubix LS
Rubix LS is announcing today the launch of it's new Data & Research division to its core business function.  This is a step for Rubix LS to strongly position its expertise base to move as a technological think tank.
By RGR Medical Products
RGR Medical products as entered into an exclusive agreement to distribute NeuroZen Rehabilitation Technologies two new diabetic neurological pain management products.
By Partners4Access
PARTNERS4ACCESS has announced the appointment of Alison Kneen as Vice President of International Operations to lead its rapidly expanding Market Access Orphan Drug Specialist team.
By Tridiagonal Solutions
Tridiagonal Solutions Inc,  provides process performance enhancement and product development solutions to worldwide clients, will be hosting a Live Two Day Training Event for Process Industry Professionals on "Mixing in the Process Industries -...
By Scitech Engineering
Three leading British biotechnology businesses have obtained grant funding from Innovate UK to investigate the manufacture of a new class of medicines, targeting a range of clinical conditions through interaction with the human microbiome.
By Partners4Access & Global Pricing Innovation
New office accommodates higher headcount reflecting rapid growth for both companies
By Aspyron Inc
Aspyron Inc. announces a Tier II qualified offering under SEC Regulation A+ of up to 2,500,000 shares of common stock at a price of $.40 per share raising up to $1,000,000
By Keystone Symposia on Molecular & Cellular Biology
Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Tech Transfer for Medical Advances: Challenges and Opportunities Commercializing Academic Biomedical Research" on February 14, 2018 at 12:00 PM ET.
By Trial Runners
Trial Runners, LLC, is pleased to announce the opening of two, new global locations. Trial Runners EU GmbH opened October 31st, 2017 and Trial Runners Australia, PTY, LTD, opened January 8th, 2018 in order to satisfy our growing global workload.
By Drugshoppe
Drugshoppe, a high-performance therapeutics development collective, adds medicinal chemist Dr. Eric Kumar and Rice University Chemical Engineering student Devon DeBalsi to its cadre of researchers.
By PD Wealth Solutions
After a relatively quiet year for mergers and acquisitions in 2017, PD Wealth Solutions' Paul Graham predicts this year will produce a bumper harvest of deals between 'Big Pharma' and Biotech.
By BioPharma
Hughes BioPharma CEO/Founder Will Lead Panel on De-Risking BioPharma Alliances
By Medikonia Limited
Uvitec Limited has appointed Medikonia Limited as exclusive distributor in Hong Kong and Macau effective 1st Jan 2018.
12685137
By Rubix LS
Rubix LS creating footprints in more areas….now in Washington DC

Page: 1 2 Next Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share